COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.

Peremiquel-Trillas P., Saura-Lázaro A., Benavente-Moreno Y., Casabonne D., Loureiro E., Cabrera S., Duran A., Garrote L., Brao I., Trelis J., Galán M., Soler F., Julià J., Cortasa D., Domínguez MÁ., Albasanz-Puig A., Gudiol C., Ramírez-Tarruella D., Muniesa J., Rivas JP., Muñoz-Montplet C., Sedano A., Plans À., Calvo-Cerrada B., Calle C., Clopés A., Carnicer-Pont D., Alemany L., Fernández E.

OBJECTIVES: Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. DESIGN: Cross-sectional study (21 May 2020-26 June 2020). SETTING: A comprehensive cancer centre (Institut Català d'Oncologia) in Catalonia, Spain. PARTICIPANTS: All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. PRIMARY OUTCOME MEASURE: Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. RESULTS: A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25-p75: 34.8-51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). CONCLUSIONS: At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Català d'Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental.

DOI

10.1136/bmjopen-2021-056637

Type

Journal article

Publication Date

2022-04-21T00:00:00+00:00

Volume

12

Keywords

COVID-19, SARS-CoV-2, antibody, epidemiology, health care workers, seroprevalence, Adult, Antibodies, Viral, COVID-19, Cross-Sectional Studies, Female, Health Personnel, Humans, Male, Neoplasms, SARS-CoV-2, Seroepidemiologic Studies, Spain

Permalink More information Close